BIO International is the largest, most influential biotech meeting in the world offering powerful business partnering, invaluable education sessions and networking with the industry’s best and brightest.
Our lawyers will be presenting on three separate panels all on Tuesday, June 16 during the convention.
Antibodies: May I Have Them All?
Presenter: Robin Silva
This session will highlight the energetic debate about the proper scope of claims covering therapeutic antibodies. Speakers will contrast evolving law in the United States (recent AbbVie case) and Europe related to functional claiming in the antibody area and discuss potential impacts on innovation and the developing pipeline.
Divide and Conquer: Licensing Strategies for Multiple Partners Around the World
Presenter: Randy Sunberg
Biotech companies with strong product candidates attract global pharma companies as well as regional players. If you strive to bring your product candidate to market on your own in your home country or region, partnering just the rest of world can be a winning strategy. Which partnering path for the rest of the world will bring your company the best return on investment for your research and development? Global out-licensing, or multiple regional licensees? Which approach will facilitate your next phase of growth? Experts from large pharma and biotech companies will explore these issues and share what they have learned from structuring a variety of deals.
Joint Purchasing/Adaptive Licensing in the EU
Presenter: Paul Ranson
In a move that could signal closer collaboration among European drug pricing authorities, France recently secured the support of more than a dozen other EU countries in an effort to bring down the cost of hepatitis drugs. The arrival of such products on the European market has led to calls for change in the Member States’ pricing and reimbursement systems. The session gives an overview of the latest topics to consider when launching a product within the European Union.